Chapter 16. None
Follow us on Facebook and Twitter, or subscribe to our mailing list, to receive news updates. Learn more.
By Amy Ellis Nutt Martin M. Katz might never have begun his groundbreaking scientific career were it not for a quirk in his vision: He was colorblind. As a budding chemist in college, that flaw forced him to reconsider his options. The result, eventually, was a PhD in psychology from the University of Texas in 1955. He went on to become a key figure in neuropsychopharmacology. Katz, who died Jan. 12 at age 89, spent more than two decades at the National Institute of Mental Health. Among his accomplishments: In a multi-institutional collaborative project at NIMH, developing a behavioral methodology to study the effects of new antidepressant drugs; designing the Katz Adjustment Scales, which created an easy-to-use checkoff method for laypeople to observe and measure over time the symptoms of mentally ill patients and track their behavioral changes from treatment; and creating the multivantage model of measurement, which insisted on the necessity of assessing patient, family, and professional views of patient symptoms and experience. The Post spoke with Katz last month. Q: You’ve said you think a lot of your success was fortuitous. How so? A: I was looking for a job in California [after graduate school], but I didn’t want to do clinical work. That was my problem. So I went back to Texas to do a postdoc. A woman who was the dean of the school was experimenting with nutrition of underfed Latino kids in Texas schools. She wanted to get a psychometric background on these kids. That was really the beginning of my career.
Link ID: 23092 - Posted: 01.13.2017
Russell Poldrack Sex, Lies, and Brain Scans: How fMRI Reveals What Really Goes on in our Minds Barbara J. Sahakian & Julia Gottwald Oxford University Press: 2017. Since its 1992 debut, functional magnetic resonance imaging (fMRI) has revolutionized our ability to view the human brain in action and understand the processes that underlie mental functions such as decision-making. As brain-imaging technologies have grown more powerful, their influence has seeped from the laboratory into the real world. In Sex, Lies, and Brain Scans, clinical neuropsychologist Barbara Sahakian and neuroscientist Julia Gottwald give a whistle-stop tour of some ways in which neuroimaging has begun to affect our views on human behaviour and society. Their discussion balances a rightful enthusiasm for fMRI with a sober appreciation of its limitations and risks. After the obligatory introduction to fMRI, which measures blood oxygenation to image neural activity, Sahakian and Gottwald address a question at the heart of neuroimaging: can it read minds? The answer largely depends on one's definition of mind-reading. As the authors outline, in recent years fMRI data have been used to decode the contents of thoughts (such as words viewed by a study participant) and mental states (such as a person's intention to carry out an action), even in sleep. These methods don't yet enable researchers to decode the 'language of thought', which is what mind-reading connotes for many. But given the growing use of advanced machine-learning methods such as deep neural networks to analyse neuroimaging data, that may just be a matter of time. © 2017 Macmillan Publishers Limited
Keyword: Brain imaging
Link ID: 23091 - Posted: 01.13.2017
Rachel Ehrenberg A protein that sounds the alarm when the body encounters something painful also helps put out the fire. Called Nav1.7, the protein sits on pain-sensing nerves and has long been known for sending a red alert to the brain when the body has a brush with pain. Now, experiments in rodent cells reveal another role for Nav1.7: Its activity triggers the production of pain-relieving molecules. The study, published online January 10 in Science Signaling, suggests a new approach to pain management that takes advantage of this protein’s dual role. “This is very interesting research,” says neuroscientist Munmun Chattopadhyay of Texas Tech University Health Sciences Center El Paso. The findings suggest that when opiates are given for certain kinds of pain relief, also targeting Nav1.7 might lessen the need for those pain relievers, Chattopadhyay says. That could reduce opiate use and their associated side effects. The new research also solves a puzzle that has frustrated researchers and pharmaceutical companies alike. People with rare mutations in the gene for making Nav1.7 feel no pain at all. That discovery, made more than a decade ago, suggested that Nav1.7 was an ideal target for controlling pain. If a drug could block Nav1.7 activity, some kinds of pain might be eradicated (SN: 6/30/12, p 22). Yet drugs designed to do just that didn’t wipe out people’s pain. “It seemed so obvious and simple,” says study leader Tim Hucho, a neuroscientist at the University Hospital Cologne in Germany. “But it was not so simple.” |© Society for Science & the Public 2000 - 2017
Keyword: Pain & Touch
Link ID: 23090 - Posted: 01.12.2017
By Tanya Lewis To the untrained listener, a bunch of babbling baboons may not sound like much. But sharp-eared experts have now found that our primate cousins can actually produce humanlike vowel sounds. The finding suggests the last common ancestor of humans and baboons may have possessed the vocal machinery for speech—hinting at a much earlier origin for language than previously thought. Researchers from the National Center for Scientific Research (CNRS) and Grenoble Alpes University, both in France, and their colleagues recorded baboons in captivity, finding the animals were capable of producing five distinct sounds that have the same characteristic frequencies as human vowels. As reported today in PLoS ONE, the animals could make these sounds despite the fact that, as dissections later revealed, they possess high voice boxes, or larynxes, an anatomical feature long thought to be an impediment to speech. “This breaks a serious logjam” in the study of language, says study co-author Thomas Sawallis, a linguist at the University of Alabama. “Theories of language evolution have developed based on the idea that full speech was only available to anatomically modern Homo sapiens,” approximately 70,000 to 100,000 years ago, he says, but in fact, “we could have had the beginnings of speech 25 million years ago.” The evolution of language is considered one of the hardest problems in science, because the process left no fossil evidence behind. One practical approach, however, is to study the mechanics of speech. Language consists roughly of different combinations of vowels and consonants. Notably, humans possess low larynxes, which makes it easier to produce a wide range of vowel sounds (and as Darwin observed, also makes it easier for us to choke on food). A foundational theory of speech production, developed by Brown University cognitive scientist Philip Lieberman in the 1960s, states the high larynxes and thus shorter vocal tracts of most nonhuman primates prevents them from producing vowel-like sounds. Yet recent research calls Lieberman’s hypothesis into question. © 2017 Scientific American
By Ashley P. Taylor Neurodegenerative diseases are often associated with aging. To learn what happens within the aging brain and potentially gain information relevant to human health, researchers examined gene-expression patterns in postmortem brain samples. Overall, the researchers found, gene expression of glial cells changed more with age than did that of neurons. These gene-expression changes were most significant in the hippocampus and substantia nigra, regions damaged in Alzheimer’s and Parkinson’s diseases, respectively, according to the study published today (January 10) in Cell Reports. “Typically we have concentrated on neurons for studies of dementia, as they are the cells involved in brain processing and memories. [This] study demonstrates that glia are likely to be equally important,” study coauthors Jernej Ule and Rickie Patani of the Francis Crick Institute and University College London wrote in an email to The Scientist. “The authors’ effort in this comprehensive work is a ‘genomic tour de force,’ showing that, overall, non-neuronal cells undergo gene expression changes at a larger scale than previously thought in aging,” Andras Lakatos, a neuroscientist at the University of Cambridge, U.K., who was not involved in the study, wrote in an email. “This finding puts glial cells again at the center stage of functional importance in neurodegenerative conditions in which aging carries a proven risk.” © 1986-2017 The Scientist
Being stressed out increases our risk of heart disease and stroke, and the key to how to counter it may lie in calming the brain, a new medical study suggests. Psychological stress has long been considered a source of sickness. But personal stress levels are difficult to measure and there isn't direct evidence of the link, even though population studies finger stress as a risk factor for cardiovascular disease just like smoking and hypertension. "I think that this relatively vague or insufficient link reduced our enthusiasm of taking stress seriously as an important risk factor," said Dr. Ahmed Tawakol, a cardiologist at Massachusetts General Hospital in Boston. Tawakol led a study published in Wednesday's online issue of The Lancet that sheds light on how the amygdala — a key part of the brain that is more active during emotional, stressful times — is linked to a greater risk of cardiovascular disease such as heart attacks and strokes. The researchers gave 293 patients aged 30 or older without cardiovascular disease PET/CT brain imaging scans, mainly for cancer screening and followed them over time. After an average of nearly four years, activity in the amygdala was significantly associated with cardiovascular events such as heart attacks, heart failure and strokes, after taking other factors into account. People with more amygdala activity also tended to suffer the events sooner, Tawakol said. ©2017 CBC/Radio-Canada.
Link ID: 23087 - Posted: 01.12.2017
Valerie Piro The alarm goes off at 4:30 a.m. Groggy, I turn on the lamp on my night stand and try to sit up. I put my right hand on the wall next to my bed to steady myself, and push my left into the bed. Right away, my abs and back seize up and my legs spasm and kick out straight, forcing me back down onto the bed. Clearly my body thinks it is too early to get up, but I don’t have time to argue with it. I have to get physical therapy out of the way so I can be on time for my medieval history class. After I sit up, I place my hands under my right knee and clasp them together as I bring my knee up and closer to my chest. I reach out to my right foot and cross its heel over my left thigh so that I can plant my heel on the bed. I hug my right leg against my torso and chest and feel a stretch in my lower back and butt. I repeat this on my other side and then proceed to stretch each ankle. Paralysis requires maintenance. I then hop toward the foot of my bed, where my commode chair sits. I set both feet on the footrests as best I can, grab the armrest on the far side of the chair with my left hand, and, using my right hand to drive down into my bed, lift myself onto the commode wheelchair, and wheel to the bathroom. I emerge at 5:35 a.m. I transfer now into a wheelchair whose dimensions are friendly toward my Functional Electrical Stimulation (F.E.S.) cycle — something like a gym exercise bike, without the seat. I pull some milk out of the mini-fridge and pour it over a bowl of cereal. I eat while checking and answering email. At 6:30 it’s time to start cycling. I put two small rectangular electrodes on my left shin muscles, and then two on my right, connect them to the cycle, then strap in my legs and feet. Then two more electrodes then two more, and so on, until most of my lower body is tapped and wired. After I turn on the tablet that’s attached to the cycle, I choose from one of several preset programs to start my workout. Within a couple of minutes, electrical shocks are pulsing into my legs, causing them to contract into pedaling. Imagine pedaling a bicycle uphill for an hour; this is my workout. © 2017 The New York Times Company
Keyword: Movement Disorders
Link ID: 23081 - Posted: 01.11.2017
By Joshua Rapp Learn The Vietnamese pygmy dormouse is as blind as a bat—and it navigates just like one, too. Scientists have found that the small, nimble brown rodent (Typhlomys cinereus chapensis), native to Vietnam and parts of China, uses sound waves to get a grip on its environment. Measurements of the mice in the Moscow Zoo revealed that the species can't see objects because of a folded retina and a low number of neurons capable of collecting visual information, among other things. When researchers recorded the animals, they discovered they make ultrasonic noises similar to those used by some bat species, and videos showed they made the sounds at a much greater pulse rate when moving than while resting. These sound waves bounce off objects, allowing the rodent to sense its surroundings—an ability known as echolocation, or biological sonar. The find makes the dormouse the only tree-climbing mammal known to use ultrasonic echolocation, the team reports in Integrative Zoology. The authors suggest that an extinct ancestor of these dormice was likely a leaf bed–dwelling animal that lost the ability to see in the darkness in which it is active. As the animals began to move up into the trees over time, they likely developed the ultrasonic echolocation abilities to help them deal with a new acrobatic lifestyle. The discovery lends support to the idea that bats may have evolved echolocation before the ability to fly. © 2017 American Association for the Advancement of Science
Link ID: 23080 - Posted: 01.11.2017
By Sally Adee Now we know – zapping the brain with electricity really does seem to improve some medical conditions, meaning it may be a useful tool for treating depression. Transcranial direct current stimulation (tDCS) involves using electrodes to send a weak current across the brain. Stimulating brain tissue like this has been linked to effects ranging from accelerated learning to improving the symptoms of depression and faster recovery from strokes. Thousands of studies have suggested the technique may be useful for everything from schizophrenia and Parkinson’s to tinnitus and autism. However, replicating such studies has generally been difficult, and two recent analyses found no evidence that tDCS is effective, leading some to say that the technique is largely a sham. “There are too many folks out there right now who are using electrical brain stimulation in a cavalier way,” says Michael Weisend, a tDCS researcher at Rio Grande Neuroscience in Santa Fe, New Mexico. “At best it has an effect that’s poorly understood, at worst it could be dangerous.” Now a review has weighed up the best available evidence. It has found that depression, addiction and fibromyalgia are most likely to respond to tDCS treatment. Jean-Pascal Lefaucheur, a neurophysiologist at Henri Mondor Hospital in Paris, France, and his team concluded this by sifting through all tDCS studies so far. Unlike the two previous analyses, this one didn’t lump together studies of variable sizes and designs. Instead, the team chose only studies that were placebo-controlled, used tDCS as a daily medical treatment, and involved at least 10 participants. © Copyright Reed Business Information Ltd.
Link ID: 23079 - Posted: 01.10.2017
Anouchka Grose Dannii Minogue has admitted to using Botox at difficult times in her life in a subconscious attempt to mask her feelings. Not only might she literally have been disabling her capacity to frown, she may also have been acting things out on her body in order to fend off her own emotions. Is America developing a ‘crack-like addiction’ to Botox beauty? Read more It’s about time someone said it. As a working therapist I have occasionally noticed my female patients’ faces change quite noticeably from week to week, but no one has ever spoken to me about what was making this happen. Cosmetic treatments, and the difficult thoughts and feelings that might make someone undergo them, are apparently one of the hardest things to talk about. On the one hand perhaps these treatments are so normalised that they do not seem worth discussing in therapy – a new study in the US shows that young women using Botox has risen by 41% since 2011 – but on the other you probably wouldn’t spend hundreds of pounds on something that carried serious health risks if you weren’t feeling pretty worried about your appearance. Doing stuff to your face is like the sunny side of self-harm; you might try it in order to short-circuit anxiety or sadness, but the end result is supposedly regeneration rather than damage. Still, nothing signals underlying unhappiness and self-loathing more than a pumped-up, frozen physiognomy. In that sense, it’s a socially acceptable form of wound. © 2017 Guardian News and Media Limited
Link ID: 23078 - Posted: 01.10.2017
By Victoria Gill Science reporter, BBC News Researchers have used camera traps to film tool-use that is unique to chimpanzees in Ivory Coast. The footage revealed that the clever primates habitually make special water-dipping sticks - chewing the end of the stick to turn it into a soft, water-absorbing brush. Primate researchers examined the "dipping sticks" and concluded they were made specifically for drinking. The findings are reported in the American Journal of Primatology. Lead researcher Juan Lapuente, from the Comoe Chimpanzee Conservation Project, in Ivory Coast, explained that using similar brush-tipped sticks to dip into bees' nests for honey was common in chimpanzee populations across Africa. "But the use of brush-tipped sticks to dip for water is completely new and had never been described before," he told BBC News. "These chimps use especially long brush tips that they make specifically for water - much longer than those used for honey." The researchers tested the chimps' drinking sticks in an "absorption experiment", which showed that the particularly long brush-tips provided an advantage. "The longer the brush, the more water they collect," said Mr Lapuente. "This technology allows Comoe chimpanzees to obtain water from extremely narrow and deep tree holes that only they - and no other animal - can exploit, which [gives] them a superb adaptive advantage to survive in this dry and unpredictable environment." © 2017 BBC.
Link ID: 23075 - Posted: 01.10.2017
By Virginia Morell Japanese macaques and sika deer live comfortably together on Japan’s Yakushima Island: The deer eat fruit the monkeys drop from the trees, and the monkeys groom and sometimes hitch a ride on the deer. But a couple years ago, one of the macaques took this relationship to a new level. Unable to get a mate of his own kind, this low-ranking snow monkey used the deer’s back for his pleasure (as pictured, and also shown in this not-suitable-for-work video). He did not penetrate her, but did ejaculate, and the deer then licked her back clean, researchers report in the current issue of Primates. The monkey was later seen attempting to mount another deer, but she objected and threatened him. He also guarded his unlikely love interests, chasing away any other male monkeys who came near. Scientists have only reported one other case of sexual relations in the wild between unrelated species. That one involved male Antarctic fur seals coercing king penguins; once, after sating his lust, the seal ate the bird. In both cases, scientists suspect that the males were unable to acquire a mate of their own kind, and seasonal hormonal surges led them to seek love elsewhere. © 2017 American Association for the Advancement of Science.
Keyword: Sexual Behavior
Link ID: 23074 - Posted: 01.10.2017
By Drake Baer Philosophers have been arguing about the nature of will for at least 2,000 years. It’s at the core of blockbuster social-psychology findings, from delayed gratification to ego depletion to grit. But it’s only recently, thanks to the tools of brain imaging, that the act of willing is starting to be captured at a mechanistic level. A primary example is “cognitive control,” or how the brain selects goal-serving behavior from competing processes like so many unruly third-graders with their hands in the air. It’s the rare neuroscience finding that’s immediately applicable to everyday life: By knowing the way the brain is disposed to behaving or misbehaving in accordance to your goals, it’s easier to get the results you’re looking for, whether it’s avoiding the temptation of chocolate cookies or the pull of darkly ruminative thoughts. Jonathan Cohen, who runs a neuroscience lab dedicated to cognitive control at Princeton, says that it underlies just about every other flavor of cognition that’s thought to “make us human,” whether it’s language, problem solving, planning, or reasoning. “If I ask you not to scratch the mosquito bite that you have, you could comply with my request, and that’s remarkable,” he says. Every other species — ape, dog, cat, lizard — will automatically indulge in the scratching of the itch. (Why else would a pup need a post-surgery cone?) It’s plausible that a rat or monkey could be taught not to scratch an itch, he says, but that would probably take thousands of trials. But any psychologically and physically able human has the capacity to do so. “It’s a hardwired reflex that is almost certainly coded genetically,” he says. “But with three words — don’t scratch it — you can override those millions of years of evolution. That’s cognitive control.” © 2017, New York Media LLC.
Link ID: 23067 - Posted: 01.07.2017
By Joshua A. Krisch At the core of Alzheimer’s disease are amyloid-beta (Aβ) peptides, which self-assemble into protein fibrils that form telltale plaques in the brain. Now, the results of a study published today (January 4) in Nature suggest that certain fibril formations are more likely to appear in cases of rapidly progressive Alzheimer’s disease, as opposed to less-severe subtypes. The findings increase scientists’ understanding of the structure of these fibrils, and may eventually contribute to new tests and treatments for Alzheimer’s disease. “It is generally believed that some form of the aggregated Aβ peptide leads to Alzheimer’s disease, and it’s conceivable that different fibril structures could lead to neurodegeneration with different degrees of aggressiveness,” said coauthor Robert Tycko, a principal investigator at the National Institute of Diabetes and Digestive Kidney Disease. “But the mechanism by which this happens is uncertain. Some structures may be more inert and benign. Others may be more inherently toxic or prone to spread throughout the brain tissue.” Prior research has demonstrated that Aβ fibrils with various molecular structures exhibit different levels of toxicity in neuronal cell cultures, a finding confirmed in subsequent mouse trials. One study even demonstrated that Aβ fibrils cultured from patients with rapidly progressive Alzheimer’s disease are different in size and resistance to chemical denaturation than those isolated from patients with more slowly progressing disease. Building on these observations, Tycko and colleagues set out to better characterize the structures of these fibrils and get a better handle on the potential correlations between structure and disease subtype. © 1986-2017 The Scientist
Link ID: 23066 - Posted: 01.07.2017
By Gary Stix The last six months have witnessed the failure of two drugs in late-stage clinical trials for which the research community had high hopes. In truth, these new reports should not have come as too much of a surprise. Drug after drug continues to show little or no effect in helping the more than 5 million patients in the U.S. diagnosed with Alzheimer’s. Scientists who study neurodegenerative diseases have started to call for new approaches that go beyond targeting the amyloid in plaques and the tau in tangles, proteins that have been thought to be culprits in killing brain cells. One organization—The Alzheimer’s Drug Discovery Foundation (ADDF)—has for years provided funding to move untried ideas into clinical trials. Howard Fillit, the organization’s executive director, recently gave Scientific American his surprisingly optimistic view of where research and drug development for Alzheimer’s is headed. There have been recent failures of late-stage clinical trials and a figure often cited is that more than 99 percent of Alzheimer's drugs fail. Given all that, what level of confidence do you have for the field moving forward? There's a lot of reason for hope. There are over 130 different clinical trials going on now. I remember the days when there were none. We have had many failures. But I think one of the big advances that is creating hope is that we know how to do clinical trials better now. In a study that is being conducted by Biogen, everyone who was recruited into that study actually had Alzheimer's disease, for the first time. © 2017 Scientific American
Link ID: 23062 - Posted: 01.06.2017
By Virginia Smart, CBC News A controversial Canadian program that gives a regulated, hourly dose of wine to alcoholics to help manage their addiction and keep them safe has caught the attention of health care researchers in Australia. The managed alcohol programs (MAPs) that have sparked the international interest have been giving new hope and new lives to many alcoholics struggling with homelessness and troubles with addiction in communities from British Columbia to Ontario. Kate Dolan, a professor at the National Drug and Alcohol Research Centre at the University of New South Wales in Australia, has visited programs in Ottawa and Vancouver and was impressed. "We used to lead the world in harm reduction services," Dolan tells the fifth estate, but "the alcohol field has not progressed as much as the illicit drug use field." Research led Dolan to Ottawa's MAP. She found MAPs to be cost-effective through reductions in spending on health care and emergency services. Participants also significantly reduce their alcohol consumption and learn a sense of community. The Pour Lucia Ali monitors 'The Pour,' the hourly distribution of a prescribed dose of alcohol dictated by the in-house nurse at the Oaks, a residence for stabilized alcoholics in Ottawa. (CBC) When participants arrive at a MAP, Dolan wrote in her study, "it is all about me, myself and I." But as they progress, they lose the "chip on their shoulder and open up." ©2016 CBC/Radio-Canada.
Keyword: Drug Abuse
Link ID: 23061 - Posted: 01.06.2017
By Alice Klein A tumour containing a miniature brain has been found growing on the ovary of a 16-year-old girl in Japan. The 10-centimetre-wide tumour was discovered when the girl had surgery to remove her appendix. When doctors cut the tumour out, they found clumps of greasy, matted hair inside, and a 3-centimetre-wide brain-like structure covered by a thin plate of skull bone. Closer analysis revealed that it was a smaller version of a cerebellum – which usually sits underneath the brain’s two hemispheres. A mass on one side resembled a brain stem – the structure that normally joins to the spinal cord. About one-fifth of ovarian tumours contain foreign tissue, including hair, teeth, cartilage, fat and muscle. These tumours, which are normally benign, are named teratomas after the Greek word “teras”, meaning monster. Although the cause of ovarian teratomas is unknown, one theory is that they arise when immature egg cells turn rogue, producing different body parts. Brain cells are often found in ovarian teratomas, but it is extremely unusual for them to organise themselves into proper brain-like structures, says Masayuki Shintaku at the Shiga Medical Centre for Adults in Japan, who studied the tumour. Angelique Riepsamen at the University of New South Wales in Australia, agrees. “Neural elements similar to that of the central nervous system are frequently reported in ovarian teratomas, but structures resembling the adult brain are rare.” © Copyright Reed Business Information Ltd.
Keyword: Development of the Brain
Link ID: 23059 - Posted: 01.06.2017
Joanne Silberner For a revolutionary, Deepali Vishwakarma of Bhopal, India, is more quiet and reflective than you might expect. She's in her 30s, small, with a round face that holds intense brown eyes and a shy grin. Vishwakarma is a lay counselor — a well-trained community member who goes out daily to fight what novelist William Styron once called a "howling tempest in the brain." She's part of an effort by the Indian nonprofit group Sangath to provide mental health treatment to poor people in India and to show that people with much less training than a psychiatrist or psychologist can deliver effective care. Vishwakarma had 40 hours of training for her role as a counselor. So her counseling is definitely revolutionary. And some mental health observers wonder if it might work in the U.S. But it's a controversial approach. Critics say the use of lay counselors means that patients receive substandard care. Tell that to Vishwakarma. In a typical week, she may meet with 25 people, and in her several years as a counselor, patients who've stuck with her, as most have, have done well. The patients have been diagnosed with serious depression (or stress or tension, as it's more often called in India), or alcoholism, and every so often, someone with schizophrenia. She's been trained to listen and to assign specific tasks to her patients. She might tell someone who's feeling really low to go for a daily walk, or go out and play soccer, or work in the garden or listen to the radio. For depression, it means thinking about anything other than that paralyzing howling tempest. For schizophrenia, it means helping people, many of whom are on medication, adjust to living in society. © 2017 npr
Link ID: 23056 - Posted: 01.05.2017
Erin Ross What lengths would you go to stifle the thunderous snorts and buzz-saw growls of a spouse or roommate, just so you can get a good night's sleep? Dozens of anti-snoring devices crowd the market, ranging from slightly absurd to moderately torturous. "Some of them are more medieval than others," says Dr. Kim Hutchison, associate professor of sleep medicine in the department of neurology at Oregon Health and Science University in Portland, Ore. And some of the devices, she says, even have some basis in fact. "When you sleep, the back of your throat relaxes. That narrows your airway and, as you're breathing in, it causes it to vibrate," explains Hutchison. So, many anti-snoring products are aimed at opening up that airway, or the tunnels that lead to it. For example, you can buy hollow nose plugs that, instead of closing the nostrils, prop them open. "If you have a deviated septum or something like that, those could help open up your nose and decrease snoring," says Hutchison, but they won't help everyone because "most snoring appears in the back of your throat." Other devices are designed to force sleepers to turn on their sides. "Sleeping on your back makes your tongue block your airway a little, sort of like the skinny part of a balloon, when you let air out of it," Hutchison says. So some devices combine straps and pillows that make sleeping on your back uncomfortable — or poke you if you roll over. © 2017 npr
Link ID: 23053 - Posted: 01.04.2017
By Michael Price We’ve all heard the stories about humans losing their jobs to robots. But what about man’s best friend? A new study suggests that drug-sniffing dogs may soon have a competitor in the workplace: an insect-piloted robotic vehicle that could help scientists build better odor-tracking robots to find disaster victims, detect illicit drugs or explosives, and sense leaks of hazardous materials. The robotic car’s driver is a silkworm moth (Bombyx mori) tethered in a tiny cockpit so that its legs can move freely over an air-supported ball, a bit like an upside-down computer mouse trackball. Using optical sensors, the car follows the ball’s movement and moves in the same direction. With its odor-sensitive antennae, the moth senses a target smell—in this case, female silkworm sex pheromones—and walks toward it along the trackball, driving the robotic car. Across seven trials with seven different drivers, the insects piloted the vehicle consistently toward the pheromones, nearly as well as 10 other silkworm moths who could walk freely on the ground toward the smells, the researchers reported last month in the Journal of Visualized Experiments. On average, the driving moths reached their target about 2 seconds behind the walking moths, although their paths were more circuitous. The researchers say their findings could help roboticists better integrate biologically inspired odor detection systems into their robots. Engineers might even be able to develop more powerful and maneuverable versions of the study’s robot car that could be driven by silkworms genetically modified to detect a wide variety of smells to help with sniffing tasks traditionally done by trained animals. Time to start polishing up those résumés, pooches. © 2016 American Association for the Advancement of Science
Keyword: Chemical Senses (Smell & Taste)
Link ID: 23051 - Posted: 01.04.2017